-
ARQT Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Arcutis Biotherapeutics (ARQT)
Company Profile
Quarter (USD) | Dec 24 | Sep 24 | Jun 24 | Mar 24 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 71.95 mm | 71.95 mm | 71.95 mm | 71.95 mm | 71.95 mm | 71.95 mm |
Cash burn (monthly) | 21.17 mm | 1.45 mm | 2.54 mm | 10.70 mm | 249.33 k | 9.35 mm |
Cash used (since last report) | 44.04 mm | 3.01 mm | 5.29 mm | 22.25 mm | 518.59 k | 19.44 mm |
Cash remaining | 27.92 mm | 68.94 mm | 66.66 mm | 49.70 mm | 71.43 mm | 52.51 mm |
Runway (months of cash) | 1.3 | 47.6 | 26.2 | 4.6 | 286.5 | 5.6 |
13F holders | Current |
---|---|
Total holders | 209 |
Opened positions | 50 |
Closed positions | 30 |
Increased positions | 58 |
Reduced positions | 64 |
13F shares | Current |
---|---|
Total value | 1.88 tn |
Total shares | 140.07 mm |
Total puts | 201.80 k |
Total calls | 2.02 mm |
Total put/call ratio | 0.1 |
Largest owners | Shares | Value |
---|---|---|
Jennison Associates | 12.34 mm | $171.89 bn |
Suvretta Capital Management | 11.40 mm | $158.79 bn |
Rubric Capital Management | 10.97 mm | $152.77 bn |
BlackRock | 9.15 mm | $127.44 bn |
Frazier Life Sciences VIII | 8.79 mm | $96.20 mm |
Frazier Life Sciences Management | 8.79 mm | $122.38 bn |
Polar Capital | 7.38 mm | $102.77 bn |
Vanguard | 6.44 mm | $89.72 bn |
STT State Street | 4.95 mm | $68.96 bn |
MS Morgan Stanley | 4.24 mm | $59.12 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
3 Feb 25 | Masaru Matsuda | Common Stock | Sell | Dispose S | No | No | 12.7 | 8,338 | 105.89 k | 178,692 |
3 Feb 25 | Todd Franklin Watanabe | Common Stock | Sell | Dispose S | No | No | 12.7 | 19,301 | 245.12 k | 804,129 |
3 Feb 25 | Howard G. Welgus | Common Stock | Sell | Dispose S | No | Yes | 12.71 | 10,000 | 127.10 k | 141,944 |
3 Feb 25 | Patrick Burnett | Common Stock | Sell | Dispose S | No | No | 12.7 | 12,116 | 153.87 k | 114,862 |
3 Feb 25 | Larry Todd Edwards | Common Stock | Sell | Dispose S | No | No | 12.7 | 2,173 | 27.60 k | 135,555 |